FDA Approves Wearable That Tracks Blood Sugar and Ketones in Diabetes Patients
The U.S. FDA approved the Libre Duo 10 Day, a wearable device from Abbott that continuously monitors both blood sugar and ketone levels in diabetes patients. The device measures both metrics every minute and sends alerts when values hit set thresholds. Abbott plans a U.S. launch during 2026.